Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Findlay

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 19, 2009
Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblastsCristina Vincent, David M Findlay, Katie J Welldon, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|August 12, 2004
The use of OP-1 in femoral impaction grafting in a sheep modelMargaret A McGee, David M Findlay, Donald W Howie, et al.
Blood|May 27, 2008
Does Apo2L/TRAIL play any physiologic role in osteoclastogenesis?Agatha Labrinidis, Vasilios Liapis, Le M Thai, et al.
Endocrinology|July 3, 2015
A Role for the Calcitonin Receptor to Limit Bone Loss During Lactation in Female Mice by Inhibiting Osteocytic OsteolysisMichele V Clarke, Patricia K Russell, David M Findlay, et al.
Bone|January 31, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitroBeiqing Pan, Luen Bik To, Amanda N Farrugia, et al.
Inflammopharmacology|October 16, 2013
Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical managementDonald W Howie, Susan D Neale, David R Haynes, et al.
Cancer Letters|December 3, 2014
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcomaVasilios Liapis, Agatha Labrinidis, Irene Zinonos, et al.
Bone|September 21, 2010
The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorptionAndrew G Turner, Francisca Tjahyono, W S Maria Chiu, et al.
Molecular and Cellular Endocrinology|November 13, 2016
Peroxidase enzymes inhibit osteoclast differentiation and bone resorptionVasilios Panagopoulos, Vasilios Liapis, Irene Zinonos, et al.
Anticancer Research|December 16, 2014
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs)Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 19, 2009
Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblastsCristina Vincent, David M Findlay, Katie J Welldon, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|August 12, 2004
The use of OP-1 in femoral impaction grafting in a sheep modelMargaret A McGee, David M Findlay, Donald W Howie, et al.
Blood|May 27, 2008
Does Apo2L/TRAIL play any physiologic role in osteoclastogenesis?Agatha Labrinidis, Vasilios Liapis, Le M Thai, et al.
Endocrinology|July 3, 2015
A Role for the Calcitonin Receptor to Limit Bone Loss During Lactation in Female Mice by Inhibiting Osteocytic OsteolysisMichele V Clarke, Patricia K Russell, David M Findlay, et al.
Bone|January 31, 2004
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitroBeiqing Pan, Luen Bik To, Amanda N Farrugia, et al.
Inflammopharmacology|October 16, 2013
Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical managementDonald W Howie, Susan D Neale, David R Haynes, et al.
Cancer Letters|December 3, 2014
Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcomaVasilios Liapis, Agatha Labrinidis, Irene Zinonos, et al.
Bone|September 21, 2010
The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorptionAndrew G Turner, Francisca Tjahyono, W S Maria Chiu, et al.
Molecular and Cellular Endocrinology|November 13, 2016
Peroxidase enzymes inhibit osteoclast differentiation and bone resorptionVasilios Panagopoulos, Vasilios Liapis, Irene Zinonos, et al.
Anticancer Research|December 16, 2014
Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs)Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, et al.
Pageof 11